TScan Therapeutics Inc
(NASDAQ:TCRX)
$2.58
-0.04[-1.53%]
Last update: 7:52AM (Delayed 15-Minutes)
Get Real Time Here
$2.58
0[0.00%]
Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open2.715Close2.560
Vol / Avg.36.104K / 126.991KMkt Cap123.372M
Day Range2.505 - 2.80552 Wk Range1.470 - 6.030
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.780-0.510 0.2700
REV4.030M3.148M-882.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-06-22WedbushDavid NierengartenInitiates Coverage OnOutperformAnnounces-8.00
2023-05-18HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-05-11HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00

Related Companies

TickerCompanyChg %Mkt Cap
TCRXTScan Therapeutics-1.53%123.4M
MOLNMolecular Partners-0.72%135.9M
GRPHGraphite Bio4.64%143.8M
GALTGalectin Therapeutics1.05%114.4M
ALTAltimmune4%137M
Q

How do I buy TScan Therapeutics (TCRX) stock?

A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TScan Therapeutics's (TCRX) competitors?

Q

What is the target price for TScan Therapeutics (TCRX) stock?

A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 481.40% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TScan Therapeutics (TCRX)?

A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.58 last updated September 22, 2023 at 11:52 AM UTC.

Q

Does TScan Therapeutics (TCRX) pay a dividend?

A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.

Q

Is TScan Therapeutics (TCRX) going to split?

A

There is no upcoming split for TScan Therapeutics.

Q

What sector and industry does TScan Therapeutics (TCRX) operate in?

A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.